Prot #GAO4753g: An Open-Label, Multicenter, Randomized, Phase III Study To Investigate The Efficacy And Safety of Bendamustine Compared With Bendamustine + RO5072759 (GA101) In Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma